ACCESSWIRE

Moderna and Merck Announce mRNA-4157/V940, Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA® (pembrolizumab), Met Primary Efficacy Endpoint in Phase 2b Trial

Elektros to Explore Expansion of Luxury EV Car Rental Fleet

Cerrado Gold Confirms over 250 Metres of Mineralized Strike at Gogó Da Onça Exploration Target at Its Monte Do Carmo Project, Brazil

The First Blockchain-Based Same Price NFT Marketplace Is Here

Oxygen Strikes Agreement with Leading Cybersecurity Firm Kudelski Security

GIB Global Investment Digital Bank To Bid For Digital Banking Licence in Vietnam